Single peptide Vial strength 20 mg
Ovagen20 mg
Explore the format, calculations, and schedules reported for this compound.
Back to peptides
Get to know the compound
Ovagen, explained simply
A synthetic tripeptide explored as a possible regulator of age-related cellular processes.
Research area
Cellular aging models and gene expression
How it works
Experiments examine markers of proliferation and aging in cell cultures.
Why it matters
This is a useful example of the difference between an in vitro finding and a demonstrated benefit in people.
What has been observed
The cited evidence is cellular or preclinical; controlled human studies of Ovagen were not identified.
Effects and points to consider
Clinical efficacy and safety for human administration have not been established.
01 / Vial strength 20 mg
Reported data
Doses and cycles are presented for information and education only; they are not prescriptions or medical advice.
Reported vial strength and reconstitution
| Vial contents | 20 mg Ovagen |
|---|---|
| Final volume | 2 mL |
| Concentration | 10 mg/mL |
| One U-100 unit | 100 mcg in 0.01 mL |
Standard / Gradual Approach (2 mL = 10 mg/mL)
| Week | Daily Dose (μg) | Units (per injection) (mL) |
|---|---|---|
| Weeks 1–2 | 10 μg (0.01 mg) | 0.1 units (0.001 mL) |
| Weeks 3–4 | 20 μg (0.02 mg) | 0.2 units (0.002 mL) |
| Weeks 5–6 | 50 μg (0.05 mg) | 0.5 units (0.005 mL) |
| Weeks 7–8 | 100 μg (0.1 mg) | 1 unit (0.01 mL) |
| Weeks 9–16 | 100–150 μg (0.1–0.15 mg) | 1–1.5 units (0.01–0.015 mL) |
Supplies needed
View on Amazon
Sterile alcohol swabs
SOURCES
Scientific references
Links reported by the source and selected by type. Their presence does not validate this page’s dosage data.